Shares of Avacta Group Plc (LON:AVCT - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 37.66 ($0.51) and traded as high as GBX 50 ($0.67). Avacta Group shares last traded at GBX 48.56 ($0.65), with a volume of 606,776 shares traded.
Avacta Group Trading Up 2.2%
The firm has a market capitalization of £196.03 million, a PE ratio of -6.64 and a beta of 1.12. The business has a 50 day moving average price of GBX 39.85 and a 200-day moving average price of GBX 37.64. The company has a current ratio of 1.29, a quick ratio of 4.96 and a debt-to-equity ratio of 52.53.
Avacta Group (LON:AVCT - Get Free Report) last issued its earnings results on Friday, June 6th. The biotechnology company reported GBX (8.54) earnings per share (EPS) for the quarter. Avacta Group had a negative return on equity of 74.00% and a negative net margin of 114.45%. Analysts expect that Avacta Group Plc will post -9.9011833 earnings per share for the current year.
About Avacta Group
(
Get Free Report)
Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.
Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).
Further Reading
Before you consider Avacta Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.
While Avacta Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access